STOCK TITAN

INSMED Inc (INSM) COO exercises 239,850 options and sells matching shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

INSMED Inc Chief Operating Officer Roger Adsett reported multiple option exercises and a same‑day share sale. He exercised three stock option grants covering a total of 239,850 shares of common stock at exercise prices of $13.67, $17.16, and $30.46 per share, with the options fully vested under a stated vesting schedule. He then sold 239,850 shares of common stock at a weighted average price of $133.27 per share, within a price range of $133.00–$133.51. One acquisition line also notes inclusion of 141 shares from the company’s 2018 Employee Stock Purchase Plan.

Positive

  • None.

Negative

  • None.
Insider Adsett Roger
Role Chief Operating Officer
Sold 239,850 shs ($31.96M)
Approx. gross sale proceeds $31.96M
Approx. exercise cost $4.91M
Approx. pre-tax spread $27.06M
Type Security Shares Price Value
Exercise Stock Option (right to buy) F3 82,280 $0.00 $0.00
Exercise Stock Option (right to buy) F3 76,600 $0.00 $0.00
Exercise Stock Option (right to buy) F3 80,970 $0.00 $0.00
Exercise Common Stock F1 82,280 $13.67 $1.12M
Exercise Common Stock 76,600 $17.16 $1.31M
Exercise Common Stock 80,970 $30.46 $2.47M
Sale Common Stock F2 239,850 $133.27 $31.96M
Holdings After Transaction: Stock Option (right to buy) — 0 shares (Direct); Common Stock — 98,744 shares (Direct)
Footnotes (3)
  1. F1. Includes 141 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
  2. F2. This is the weighted average sales price representing 239,850 shares sold at prices ranging from $133.00 to $133.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. F3. The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Shares sold 239,850 shares Common stock sale on 2026-08-10 at weighted average price
Weighted average sale price $133.27 per share 239,850 INSM shares sold within $133.00–$133.51 range
Option exercise shares 239,850 shares Total underlying common shares from three Stock Option exercises
Option exercise price 1 $13.67 per share Exercise price for 82,280-share Stock Option grant expiring 2027-01-05
Option exercise price 2 $17.16 per share Exercise price for 76,600-share Stock Option grant expiring 2027-05-17
Option exercise price 3 $30.46 per share Exercise price for 80,970-share Stock Option grant expiring 2028-01-04
ESPP shares included 141 shares Acquired through the Company’s 2018 Employee Stock Purchase Plan
Stock Option (right to buy) financial
"security_title is reported as Stock Option (right to buy) for three grants"
weighted average sales price financial
"This is the weighted average sales price representing 239,850 shares sold"
Employee Stock Purchase Plan financial
"Includes 141 shares acquired through the Company's 2018 Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
vesting schedule financial
"The options became exercisable based on the following vesting schedule"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.

FAQ

What did INSM (INSMED Inc) COO Roger Adsett report in this Form 4?

Roger Adsett reported exercising options for 239,850 shares of INSM common stock and selling 239,850 shares on the same date, all in direct holdings, as part of routine equity compensation activity.

How many INSM (INSMED Inc) shares did Roger Adsett sell and at what price?

Roger Adsett sold 239,850 INSM shares at a weighted average price of $133.27 per share, with actual sale prices ranging from $133.00 to $133.51 per share, according to the filing footnote.

What option exercise prices were involved in Roger Adsett’s INSM transactions?

The option exercises covered INSM common stock at $13.67, $17.16, and $30.46 per share. Each grant was reported as a Stock Option (right to buy) with fully vested schedules described in a footnote.

Were all of Roger Adsett’s INSM transactions direct or through an entity?

All reported INSM transactions were classified as direct ownership. The filing does not indicate any trusts, funds, or other entities holding voting or investment power for these specific option exercises and share sales.

Did the INSM COO’s Form 4 indicate a Rule 10b5-1 trading plan?

The Form 4’s Rule 10b5‑1 checkbox is marked false, and no footnote references such a plan. The filing therefore does not state that these INSM transactions were executed under a pre‑arranged trading plan.

What additional INSM shares did Roger Adsett acquire via the employee stock plan?

One acquisition entry notes that his holdings include 141 shares acquired through INSM’s 2018 Employee Stock Purchase Plan, indicating ongoing participation in the company’s employee share purchase program.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Adsett Roger

(Last)(First)(Middle)
700 US HIGHWAY 202/206

(Street)
BRIDGEWATER NEW JERSEY 08807

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
INSMED Inc [ INSM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/10/2026M82,280A$13.67181,024(1)D
Common Stock08/10/2026M76,600A$17.16257,624D
Common Stock08/10/2026M80,970A$30.46338,594D
Common Stock08/10/2026S239,850D$133.27(2)98,744D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$13.6708/10/2026M82,280 (3)01/05/2027Common Stock82,280$00D
Stock Option (right to buy)$17.1608/10/2026M76,600 (3)05/17/2027Common Stock76,600$00D
Stock Option (right to buy)$30.4608/10/2026M80,970 (3)01/04/2028Common Stock80,970$00D
Explanation of Responses:
1. Includes 141 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
2. This is the weighted average sales price representing 239,850 shares sold at prices ranging from $133.00 to $133.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
3. The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Remarks:
/s/ Roger Adsett, by Michael A. Smith as Attorney-in-fact08/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)